Published in J Clin Oncol on August 01, 1999
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol (2014) 6.61
A prospective study of mediastinal gray-zone lymphoma. Blood (2014) 1.08
Method comparison of automated matching software-assisted cone-beam CT and stereoscopic kilovoltage x-ray positional verification image-guided radiation therapy for head and neck cancer: a prospective analysis. Phys Med Biol (2009) 0.82
Beyond PET/CT in Hodgkin lymphoma: a comprehensive review of the role of imaging at initial presentation, during follow-up and for assessment of treatment-related complications. Insights Imaging (2015) 0.82
Large mediastinal tumor mass as a prognostic factor in Hodgkin's lymphoma. Is the definition on the basis of a chest radiograph in the era of CT obsolete? Strahlenther Onkol (2012) 0.78
Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes. Haematologica (2016) 0.78
Cryptococcosis in HIV-negative Patients with Renal Dialysis: A Retrospective Analysis of Pooled Cases. Mycopathologia (2017) 0.75
Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors. Clin Med Insights Oncol (2017) 0.75
Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood (1998) 2.83
Alternate splicing produces a novel cyclin D1 transcript. Oncogene (1995) 2.48
Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. Radiother Oncol (2000) 2.07
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (2001) 1.99
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury. J Clin Oncol (1999) 1.76
Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours. Br J Cancer (2008) 1.74
Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas. J Clin Oncol (2000) 1.63
Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast. J Pathol (1996) 1.49
Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial. Blood (1992) 1.45
The value of hyoscine butylbromide in pelvic MRI. Clin Radiol (2007) 1.43
2-chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphoma. Ann Oncol (1996) 1.43
Staging of advanced cervical carcinoma using MRI-predictors of outcome after radical radiotherapy. Clin Radiol (2003) 1.42
Changes in lipoprotein(a) levels measured by six kit methods during growth hormone treatment of growth hormone-deficient adults. Growth Horm IGF Res (2000) 1.39
Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer (1996) 1.38
Growth hormone and tumour recurrence. BMJ (1992) 1.30
Predicting septic complications of chemotherapy: an analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsis. Eur J Cancer (1992) 1.22
Chemotherapy for ovarian cancer--a consensus statement on standard practice. Br J Cancer (1998) 1.19
Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant. Cancer (1994) 1.16
Requirement for expert histopathological assessment of ovarian cancer and borderline tumors. Br J Cancer (2000) 1.08
Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood (1993) 1.08
Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (2000) 1.08
Isolation of germ cells from human testicular tissue for low temperature storage and autotransplantation. Fertil Steril (2001) 1.07
Massive haemoptysis death and other morbidity associated with high dose rate intraluminal radiotherapy for carcinoma of the bronchus. Radiother Oncol (1996) 1.02
Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphoma. J Clin Oncol (2004) 1.00
Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen. J Clin Oncol (1995) 0.98
Mitomycin C and vinblastine in the treatment of advanced breast cancer. Eur J Cancer Clin Oncol (1985) 0.98
Response evaluation in gastrointestinal stromal tumours treated with imatinib: misdiagnosis of disease progression on CT due to cystic change in liver metastases. Br J Radiol (2006) 0.98
Survival times of Provox valves. J Laryngol Otol (1996) 0.96
Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma. Br J Cancer (1989) 0.96
Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy. Clin Endocrinol (Oxf) (2001) 0.95
Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease. J Clin Oncol (1995) 0.94
Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency. J Clin Oncol (1999) 0.94
The value of specialist oncological radiology review of cross-sectional imaging. Clin Radiol (1999) 0.90
Sequential high dose chemotherapy as initial treatment for aggressive sub-types of non-Hodgkin lymphoma: results of the international randomized phase III trial (MISTRAL). Ann Oncol (2006) 0.90
Prognostic relevance of micro-vessel density in cancer of the urinary bladder. Anticancer Res (2000) 0.90
Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes. Br J Cancer (1999) 0.90
Semen cryopreservation, utilisation and reproductive outcome in men treated for Hodgkin's disease. Br J Cancer (2002) 0.89
Growth hormone treatment of children with brain tumors and risk of tumor recurrence. J Clin Endocrinol Metab (2000) 0.89
The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage. Br J Cancer (2009) 0.88
Predictive value of clinical examination, transrectal ultrasound and magnetic resonance imaging prior to radiotherapy in carcinoma of the cervix. Br J Radiol (1998) 0.88
The post-cystectomy pseudotumour sign: MRI appearances of a modified chronic pelvic haematoma due to retained haemostatic gauze. Clin Radiol (2000) 0.88
Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: a two centre study. Ann Oncol (2000) 0.88
Magnetic resonance appearance of normal inguinal nodes. Clin Radiol (2000) 0.87
Fatigue, sexual function and mood following treatment for haematological malignancy: the impact of mild Leydig cell dysfunction. Br J Cancer (2000) 0.87
All-trans retinoic acid (ATRA) and tranexamic acid: a potentially fatal combination in acute promyelocytic leukaemia. Br J Haematol (2000) 0.87
Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma. Br J Oral Maxillofac Surg (2010) 0.86
Postirradiation changes in the pelvis: assessment with MR imaging. Radiology (1990) 0.86
A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma. Br J Cancer (2001) 0.86
Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix. Br J Cancer (2009) 0.85
An audit of primary surgical treatment for women with ovarian cancer referred to a cancer centre. Br J Cancer (1999) 0.85
Pelvic radiation disease. Clin Radiol (1992) 0.84
Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer. Br J Cancer (1990) 0.84
Late radiation change in the CNS: MR imaging following gadolinium enhancement. Clin Radiol (1997) 0.82
Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma. J Clin Oncol (1999) 0.82
Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma. J Clin Oncol (1996) 0.82
The relationship between serum GH and serum IGF-I in acromegaly is gender-specific. J Clin Endocrinol Metab (2001) 0.81
The evolution of radiation-induced growth hormone deficiency in adults is determined by the baseline growth hormone status. Clin Endocrinol (Oxf) (1995) 0.81
A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma. Ann Oncol (2000) 0.81
Prognostic factors for disease progression in advanced Hodgkin's disease: an analysis of patients aged under 60 years showing no progression in the first 6 months after starting primary chemotherapy. Br J Cancer (1997) 0.81
Magnetic resonance imaging of anal cancer. Clin Radiol (2005) 0.81
Suitability of cisplatin solutions for 14-day continuous infusion by ambulatory pump. Cancer Chemother Pharmacol (1992) 0.80
Magnetic resonance imaging of primary vaginal carcinoma. Clin Radiol (2007) 0.80
Patterns of mortality after prolonged follow-up of a randomised controlled trial using granulocyte colony-stimulating factor to maintain chemotherapy dose intensity in non-Hodgkin's lymphoma. Br J Cancer (2008) 0.80
Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors. Br J Cancer (2013) 0.80
A randomized, controlled trial of acupuncture self-needling as maintenance therapy for cancer-related fatigue after therapist-delivered acupuncture. Ann Oncol (2013) 0.80
Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519). Ann Oncol (2009) 0.80
Validation of a model to predict survival in elderly patients with acute myeloid leukaemia. Br J Haematol (1995) 0.79
The assessment of irradiated bladder carcinoma using dynamic contrast-enhanced MR imaging. Clin Radiol (2001) 0.79
The impact of mild Leydig cell dysfunction following cytotoxic chemotherapy on bone mineral density (BMD) and body composition. Clin Endocrinol (Oxf) (2000) 0.79
Cerebral metastasis and other cerebral events in women with ovarian cancer. Clin Radiol (2002) 0.79
The role of computed tomography in the management of ovarian tumours of borderline malignancy. Clin Radiol (1997) 0.79
Radiotherapy for carcinoma of the posterior pharyngeal wall. Int J Oncol (2000) 0.78
A comparative study of the nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease. J Clin Oncol (1989) 0.78
An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPP. Ann Oncol (1991) 0.78
International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury. Ann Oncol (1999) 0.78
Unusual sites of lymph node metastases and pitfalls in their detection. Clin Radiol (2004) 0.78
A randomised study of bolus vs continuous pump infusion of ifosfamide and doxorubicin with oral etoposide for small cell lung cancer. Br J Cancer (1993) 0.77
Accuracy of axillary MR imaging in treated breast cancer for distinguishing between recurrent tumour and treatment effects: does intravenous Gd-DTPA enhancement help in cases of diagnostic dilemma? Clin Radiol (2000) 0.77
Accuracy in staging carcinoma of the bladder by magnetic resonance imaging. Clin Radiol (1990) 0.76
Paradoxical elevations in serum IGF-II and IGF binding protein-2 in acromegaly: insights into the regulation of these peptides. Clin Endocrinol (Oxf) (2001) 0.76
Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study. Clin Oncol (R Coll Radiol) (2010) 0.76
CT during arterial portography: comparison of injection into the splenic versus superior mesenteric artery. Radiology (1996) 0.76
Monocytoid B cell lymphoma. J Clin Pathol (1991) 0.76
The effect of radiotherapy treatment changes on sites of relapse in stage I testicular seminoma. Clin Radiol (2001) 0.75
Abdominopelvic CT scan findings after surgery for ovarian cancer. Clin Radiol (1998) 0.75
Limited field radiotherapy for early stage, infra-diaphragmatic Hodgkin's lymphoma. Clin Oncol (R Coll Radiol) (2004) 0.75
What is the value of the lateral chest radiograph in the follow-up thoracic lymphoma? Eur Radiol (1997) 0.75
A doxorubicin-based regimen used in the treatment of elderly patients with high-grade non-Hodgkin's lymphoma. Clin Oncol (R Coll Radiol) (2000) 0.75
Relationship of MRI and clinical staging to outcome in invasive bladder cancer treated by radiotherapy. Clin Radiol (2000) 0.75
Post-radiotherapy osteomyelitis of the symphysis pubis: computed tomographic features. Clin Radiol (1998) 0.75
Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer. J Clin Oncol (1998) 0.75